Inhaled SNSP113: Clinical Trials

1 trial of Inhaled SNSP113, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow Inhaled SNSP113: new trials by email Literature Review of Inhaled SNSP113 trials Research Report on Inhaled SNSP113

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
Inhaled SNSP113, Inhaled Placebo - Lung Diseases, Pulmonary Disease
Phase 1TerminatedSynspira, Inc.322017-09-282018-05-25

Conditions studied

Burkholderia Infections (1)  ·  Cystic Fibrosis (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Mycobacterium Infections, Nontuberculous (1)  ·  Pneumonia (1)  ·  Respiratory Tract Diseases (1)

Sponsors

Synspira, Inc. (1)

Countries

United Kingdom (1)

Top investigators

Maria Theresa Basco, MD, MPH (1)